Cargando…

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders

INTRODUCTION: The aim of this study was to describe the number and type of drugs used to treat depressive disorders in inpatient psychiatry and to analyse the determinants of potential drug-drug interactions (pDDI) and potentially inappropriate medication (PIM). METHODS: Our study was part of a larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolff, Jan, Reißner, Pamela, Hefner, Gudrun, Normann, Claus, Kaier, Klaus, Binder, Harald, Hiemke, Christoph, Toto, Sermin, Domschke, Katharina, Marschollek, Michael, Klimke, Ansgar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297778/ https://www.ncbi.nlm.nih.gov/pubmed/34293068 http://dx.doi.org/10.1371/journal.pone.0255192

Ejemplares similares

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
por: Wolff, Jan, et al.
Publicado: (2021)

Predicting the risk of drug-drug interactions in psychiatric hospitals
por: Wolff, J., et al.
Publicado: (2021)

Predicting patient outcomes in psychiatric hospitals with routine data: a machine learning approach
por: Wolff, J., et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
por: Moschny, Nicole, et al.
Publicado: (2021)

Hospital costs associated with psychiatric comorbidities: a retrospective study
por: Wolff, Jan, et al.
Publicado: (2018)

Forecasting admissions in psychiatric hospitals before and during Covid-19: a retrospective study with routine data
por: Wolff, J., et al.
Publicado: (2022)

Predictors of length of stay in psychiatry: analyses of electronic medical records
por: Wolff, Jan, et al.
Publicado: (2015)

Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries
por: Reinhard, Matthias A., et al.
Publicado: (2020)

Transcranial Magnetic Stimulation in Psychiatry: Is There a Need for Electric Field Standardization?
por: Turi, Zsolt, et al.
Publicado: (2021)

Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023)

The interactions between COVID-19 drugs and psychotropic agents
por: Hiemke, C.
Publicado: (2021)

Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
por: Miziak, Barbara, et al.
Publicado: (2021)

Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update
por: Seifert, Johanna, et al.
Publicado: (2021)

Drug Utilization and Inappropriate Prescribing in Centenarians
por: Hazra, Nisha C., et al.
Publicado: (2016)

Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection
por: Klimke, A., et al.
Publicado: (2020)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

Hidden Paradoxes in Generic Drug Substitution Affecting Pharmacotherapy
por: Sapone, A., et al.
Publicado: (2009)

Drug pollution and pharmacotherapy in psychiatry: A “platypus” in the room
por: Lertxundi, Unax, et al.
Publicado: (2020)

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future
por: Navarini, Luca, et al.
Publicado: (2020)

Pharmacotherapy of Adolescent Alcohol and Other Drug Use Disorders
por: Solhkhah, Ramon, et al.
Publicado: (1998)

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023)

Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
por: Bernatoniene, Jurga, et al.
Publicado: (2023)

Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program
por: Friedrich, Michaela-Elena, et al.
Publicado: (2015)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug
por: Freese, Christian, et al.
Publicado: (2014)

Induction of Drug Transporters Alters Disposition of Risperidone - A Study in Mice
por: Holthoewer, David, et al.
Publicado: (2010)

Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use
por: Pickar, David, et al.
Publicado: (2008)

Drug Interactions in Parkinson’s Disease: Safety of Pharmacotherapy for Arterial Hypertension
por: Bitner, Anna, et al.
Publicado: (2015)

Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents
por: Caldano, Marzia, et al.
Publicado: (2017)

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
por: Chakhtoura, Marlene, et al.
Publicado: (2023)

Inappropriate prescribing and adverse drug events in older people
por: Hamilton, Hilary J, et al.
Publicado: (2009)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)

Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy
por: Wu, Di, et al.
Publicado: (2022)

A Narrative Review of Antiviral Drugs Used for COVID-19 Pharmacotherapy
por: Kumar, Subodh, et al.
Publicado: (2021)

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery
por: Zięba, Agata, et al.
Publicado: (2023)

Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs
por: Varadharajan, Ashvin, et al.
Publicado: (2023)

Rates of inappropriate antiretroviral prescription among injection drug users
por: Wood, Evan, et al.
Publicado: (2007)

Potentially inappropriate anticholinergic drug prescriptions for patients with Sjögren's syndrome
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5aq35m89qk9l6pdq2rnpsg05ib